Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections.
Isakova-Sivak I, Matyushenko V, Stepanova E, Matushkina A, Kotomina T, Mezhenskaya D, Prokopenko P, Kudryavtsev I, Kopeykin P, Sivak K, Rudenko L. Isakova-Sivak I, et al. Among authors: rudenko l. Vaccines (Basel). 2020 Apr 24;8(2):196. doi: 10.3390/vaccines8020196. Vaccines (Basel). 2020. PMID: 32344618 Free PMC article.
Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).
Isakova-Sivak I, Chen LM, Matsuoka Y, Voeten JT, Kiseleva I, Heldens JG, den Bosch Hv, Klimov A, Rudenko L, Cox NJ, Donis RO. Isakova-Sivak I, et al. Among authors: rudenko l. Virology. 2011 Apr 10;412(2):297-305. doi: 10.1016/j.virol.2011.01.004. Epub 2011 Feb 18. Virology. 2011. PMID: 21315402 Free article.
Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, Dong L, Isakova-Sivak I, Chen LM, Voeten JT, Heldens JG, van den Bosch H, Cox NJ, Tumpey TM, Klimov AI, Rudenko L, Donis RO, Katz JM. Gustin KM, et al. Among authors: rudenko l. J Infect Dis. 2011 Nov 15;204(10):1491-9. doi: 10.1093/infdis/jir596. Epub 2011 Sep 28. J Infect Dis. 2011. PMID: 21957153
Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, Stukova M, Donina S, Petukhova G, Pisareva M, Krivitskaya V, Grudinin M, Buzitskaya Z, Isakova-Sivak I, Kuznetsova S, Larionova N, Desheva J, Dubrovina I, Nikiforova A, Victor JC, Neuzil K, Flores J, Tsvetnitsky V, Kiselev O. Rudenko L, et al. PLoS One. 2014 Feb 12;9(2):e87962. doi: 10.1371/journal.pone.0087962. eCollection 2014. PLoS One. 2014. PMID: 24533064 Free PMC article. Clinical Trial.
Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
Isakova-Sivak I, Chen LM, Bourgeois M, Matsuoka Y, Voeten JT, Heldens JG, van den Bosch H, Klimov A, Rudenko L, Cox NJ, Donis RO. Isakova-Sivak I, et al. Among authors: rudenko l. Clin Vaccine Immunol. 2014 May;21(5):722-31. doi: 10.1128/CVI.00819-13. Epub 2014 Mar 19. Clin Vaccine Immunol. 2014. PMID: 24648485 Free PMC article.
Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
Isakova-Sivak I, de Jonge J, Smolonogina T, Rekstin A, van Amerongen G, van Dijken H, Mouthaan J, Roholl P, Kuznetsova V, Doroshenko E, Tsvetnitsky V, Rudenko L. Isakova-Sivak I, et al. Among authors: rudenko l. PLoS One. 2014 Jul 24;9(7):e102339. doi: 10.1371/journal.pone.0102339. eCollection 2014. PLoS One. 2014. PMID: 25058039 Free PMC article.
354 results